Cyproconazole

Target genes for Cyproconazole is obtained based on ToxCast assay component endpoints.
Chemical nameGene identifierToxCast assay component endpoint name
CyproconazoleNR1H3ATG_DR4_LXR_CIS_dn
CyproconazoleNACEETOX_H295R_PROG_dn
CyproconazoleESR1CEETOX_H295R_ESTRONE_dn
CyproconazoleESR1CEETOX_H295R_ESTRADIOL_dn
CyproconazoleNACEETOX_H295R_ANDR_dn
CyproconazoleCHRM4NVS_GPCR_hM4
CyproconazoleCYP1A1CLD_CYP1A1_6hr
CyproconazoleCYP1A1CLD_CYP1A1_24hr
CyproconazoleCYP1A2CLD_CYP1A2_48hr
CyproconazoleCYP1A2CLD_CYP1A2_24hr
CyproconazoleCYP1A2CLD_CYP1A2_6hr
CyproconazoleCYP2B6CLD_CYP2B6_24hr
CyproconazoleCYP2B6CLD_CYP2B6_48hr
CyproconazoleCYP2B6CLD_CYP2B6_6hr
CyproconazoleCYP2B6NVS_ADME_hCYP2B6
CyproconazoleCYP2C19NVS_ADME_hCYP2C19
CyproconazoleCYP2C9NVS_ADME_hCYP2C9
CyproconazoleCYP2C9CLD_CYP2C9_48hr
CyproconazoleCYP2C18NVS_ADME_hCYP2C18
CyproconazoleCYP3A4NVS_ADME_hCYP3A4
CyproconazoleCYP3A4CLD_CYP3A4_24hr
CyproconazoleCYP19A1TOX21_Aromatase_Inhibition
CyproconazoleCYP19A1NVS_ADME_hCYP19A1
CyproconazoleESR1CEETOX_H295R_ESTRONE_dn
CyproconazoleESR1ATG_ERa_TRANS_up
CyproconazoleESR1ATG_ERE_CIS_up
CyproconazoleESR1CEETOX_H295R_ESTRADIOL_dn
CyproconazoleESR2CEETOX_H295R_ESTRONE_dn
CyproconazoleESR2OT_ER_ERbERb_0480
CyproconazoleESR2OT_ER_ERbERb_1440
CyproconazoleESR2CEETOX_H295R_ESTRADIOL_dn
CyproconazoleESR2TOX21_ERb_BLA_Antagonist_ratio
CyproconazoleNR3C1CEETOX_H295R_11DCORT_dn
CyproconazoleNR3C1CEETOX_H295R_CORTISOL_dn
CyproconazoleNR3C1NVS_NR_hGR
CyproconazoleARTOX21_AR_BLA_Antagonist_ratio
CyproconazoleARCEETOX_H295R_ANDR_dn
CyproconazoleARNVS_NR_hAR
CyproconazoleARACEA_AR_antagonist_80hr
CyproconazoleESR1CEETOX_H295R_ESTRADIOL_dn
CyproconazoleESR1CEETOX_H295R_ESTRONE_dn
CyproconazoleNACEETOX_H295R_ESTRADIOL_dn
CyproconazoleNACEETOX_H295R_ESTRONE_dn
CyproconazoleARCEETOX_H295R_ANDR_dn
CyproconazoleNR3C2CEETOX_H295R_11DCORT_dn
CyproconazoleNR3C2CEETOX_H295R_CORTISOL_dn
CyproconazoleNFE2L2TOX21_ARE_BLA_agonist_ratio
CyproconazolePGRCEETOX_H295R_PROG_dn
CyproconazolePGRCEETOX_H295R_OHPROG_dn
CyproconazolePGRTOX21_PR_BLA_Antagonist_ratio
CyproconazolePGRCEETOX_H295R_OHPREG_dn
CyproconazoleSLC6A3NVS_TR_hDAT
CyproconazoleTGFB1BSK_BE3C_TGFb1_down
CyproconazoleTNFBSK_LPS_TNFa_up
CyproconazoleNR1H2ATG_DR4_LXR_CIS_dn
CyproconazoleVDRATG_VDRE_CIS_up
CyproconazoleNACEETOX_H295R_ANDR_dn
CyproconazoleNR1I2ATG_PXRE_CIS_up
CyproconazoleNR1I3NVS_NR_hCAR_Antagonist

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.